CLINICAL_TRIALS
trial_result
· 2014-12-03
Clinical Trial Update: Safety and Pharmacokinetics of SAR245408 Daily Oral in Patients With Solid Tumors [Phase 1]
Summary
This Phase 1 trial update reports the safety and pharmacokinetic profile of daily oral SAR245408 in patients with solid tumors.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Neoplasm Malignant | Phase 1 | Status: COMPLETED